 | • レポートコード：MRC2302E0037 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、244ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社では、2021年に3,659.62百万ドルであった世界の微生物同定試験市場規模が、2022年に4,152.86百万ドルに達し、2027年には年平均成長率13.65%で7,888.00百万ドルまで成長すると予測しています。当調査レポートでは、微生物同定試験の世界市場の現状について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、競争状況などの構成でまとめております。セグメント分析では、製品・サービス別（消耗品、機器、サービス）、方式別（遺伝子型法、表現型法、プロテオーム方法）、技術別（フローサイトメトリー、質量分析、顕微鏡検査、ポリメラーゼ連鎖反応(PCR)）、用途別（飲料試験、化粧品＆パーソナルケア製品試験、環境用、食品試験、その他）、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）の情報が含まれています。なお、当市場の主要企業には、Accelerate Diagnostics, Inc.、Alifax S.R.L.、Avantor, Inc.、Beckman Coulter Inc、Becton, Dickinson And Company、Biolog, Inc.、Biomérieux SA、Bruker Corporation、Creative Diagnostics、Genefluidics, Inc.、Gradian Diagnostics Inc、Himedia Laboratories、I2a Sa、Liofilchem S.R.L.、Merck Kgaa、Qiagen Nv、Shimadzu Corporationなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の微生物同定試験市場規模：製品・サービス別 - 消耗品の市場規模 - 機器の市場規模 - サービスの市場規模 ・世界の微生物同定試験市場規模：方式別 - 遺伝子型法微生物同定試験の市場規模 - 表現型法微生物同定試験の市場規模 - プロテオーム方法微生物同定試験の市場規模 ・世界の微生物同定試験市場規模：技術別 - フローサイトメトリー技術の市場規模 - 質量分析技術の市場規模 - 顕微鏡検査技術の市場規模 - ポリメラーゼ連鎖反応(PCR)技術の市場規模 ・世界の微生物同定試験市場規模：用途別 - 飲料試験の市場規模 - 化粧品＆パーソナルケア製品試験の市場規模 - 環境用試験の市場規模 - 食品試験の市場規模 - その他用途の市場規模 ・世界の微生物同定試験市場規模：地域別 - 南北アメリカの微生物同定試験市場規模 アメリカの微生物同定試験市場規模 カナダの微生物同定試験市場規模 ブラジルの微生物同定試験市場規模 … - アジア太平洋の微生物同定試験市場規模 日本の微生物同定試験市場規模 中国の微生物同定試験市場規模 インドの微生物同定試験市場規模 韓国の微生物同定試験市場規模 台湾の微生物同定試験市場規模 … - ヨーロッパ/中東/アフリカの微生物同定試験市場規模 イギリスの微生物同定試験市場規模 ドイツの微生物同定試験市場規模 フランスの微生物同定試験市場規模 ロシアの微生物同定試験市場規模 … - その他地域の微生物同定試験市場規模 ・競争状況 ・企業情報 |
The Global Microbial Identification Market size was estimated at USD 3,659.62 million in 2021 and expected to reach USD 4,152.86 million in 2022, and is projected to grow at a CAGR 13.65% to reach USD 7,888.00 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Microbial Identification to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product and Service, the market was studied across Consumables, Instruments, and Services.
Based on Method, the market was studied across Genotypic Method, Phenotypic Method, and Proteomic-based Method.
Based on Technology, the market was studied across Flow Cytometry, Mass Spectrometry, Microscopy, and Polymerase Chain Reaction (PCR).
Based on Application, the market was studied across Beverage Testing, Cosmetics & Personal Care Products Testing, Diagnostic, Environmental Applications, Food Testing, and Pharmaceutical.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Microbial Identification market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Microbial Identification Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Microbial Identification Market, including Accelerate Diagnostics, Inc., Alifax S.R.L., Avantor, Inc., Beckman Coulter Inc, Becton, Dickinson And Company, Biolog, Inc., Biomérieux SA, Bruker Corporation, Creative Diagnostics, Genefluidics, Inc., Gradian Diagnostics Inc, Himedia Laboratories, I2a Sa, Liofilchem S.R.L., Merck Kgaa, Qiagen Nv, Shimadzu Corporation, Thermo Fisher Scientific Inc., Trivitron Healthcare, and Zhuhai Dl Biotech Co., Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Microbial Identification Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Microbial Identification Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Microbial Identification Market?
4. What is the competitive strategic window for opportunities in the Global Microbial Identification Market?
5. What are the technology trends and regulatory frameworks in the Global Microbial Identification Market?
6. What is the market share of the leading vendors in the Global Microbial Identification Market?
7. What modes and strategic moves are considered suitable for entering the Global Microbial Identification Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Government policies and financial support for microbial identification
5.1.1.2. Rising prevalence of infectious disease and threats of pandemics
5.1.1.3. Increasing challenges and concerns regarding food safety
5.1.2. Restraints
5.1.2.1. High cost associated with the microbial identification process
5.1.3. Opportunities
5.1.3.1. Rising efforts towards bioterrorism surveillance
5.1.3.2. Automatic systems for microbial identification
5.1.3.3. Proliferating end-use industries in emerging economies
5.1.4. Challenges
5.1.4.1. Limitations of traditional microbial testing
5.2. Cumulative Impact of COVID-19
6. Microbial Identification Market, by Product and Service
6.1. Introduction
6.2. Consumables
6.3. Instruments
6.4. Services
7. Microbial Identification Market, by Method
7.1. Introduction
7.2. Genotypic Method
7.3. Phenotypic Method
7.4. Proteomic-based Method
8. Microbial Identification Market, by Technology
8.1. Introduction
8.2. Flow Cytometry
8.3. Mass Spectrometry
8.4. Microscopy
8.5. Polymerase Chain Reaction (PCR)
9. Microbial Identification Market, by Application
9.1. Introduction
9.2. Beverage Testing
9.3. Cosmetics & Personal Care Products Testing
9.4. Diagnostic
9.5. Environmental Applications
9.6. Food Testing
9.7. Pharmaceutical
10. Americas Microbial Identification Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Microbial Identification Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Microbial Identification Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Accelerate Diagnostics, Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Alifax S.R.L.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Avantor, Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Beckman Coulter Inc
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Becton, Dickinson And Company
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Biolog, Inc.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Biomérieux SA
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Bruker Corporation
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Creative Diagnostics
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Genefluidics, Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Gradian Diagnostics Inc
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Himedia Laboratories
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. I2a Sa
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Liofilchem S.R.L.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Merck Kgaa
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Qiagen Nv
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Shimadzu Corporation
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Thermo Fisher Scientific Inc.
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Trivitron Healthcare
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Zhuhai Dl Biotech Co., Ltd.
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing